ScopeMD

013 Overview of Immunotherapy for Healthcare Providers, Cancer Patients and their Families

July 15, 2020
ScopeMD
013 Overview of Immunotherapy for Healthcare Providers, Cancer Patients and their Families
Chapters
ScopeMD
013 Overview of Immunotherapy for Healthcare Providers, Cancer Patients and their Families
Jul 15, 2020

This episode is designed for healthcare providers who are not oncologists as well as cancer patients and their families who are interested in learning about immunotherapy.

Dr. Joe Leach provides an overview of the role of immunotherapy in cancer treatment, including the history of immunotherapy,  what cancers are currently treated with immunotherapy, and the future of immunotherapy.

Dr. Joe Leach is an oncologist at Minnesota Oncology and is Chief Medical Officer at Prime Therapeutics.

Resources
A Breath of Hope Lung Foundation - Treatment and Management of Lung Cancer Video
http://www.youandlungcancer.com/en-lc/view/m401-a05-treatment-and-management-of-non-small-cell-lung-cancer-nsclc-animation

American Cancer Society
https://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/immunotherapy.html

Journal article referenced in this episode:
Hellmann, Matthew D. et al "Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLC." Clinical Cancer Research 26.12 (2020): 2849-2858. Web. 11 July. 2020.
https://clincancerres.aacrjournals.org/content/26/12/2849

Show Notes

This episode is designed for healthcare providers who are not oncologists as well as cancer patients and their families who are interested in learning about immunotherapy.

Dr. Joe Leach provides an overview of the role of immunotherapy in cancer treatment, including the history of immunotherapy,  what cancers are currently treated with immunotherapy, and the future of immunotherapy.

Dr. Joe Leach is an oncologist at Minnesota Oncology and is Chief Medical Officer at Prime Therapeutics.

Resources
A Breath of Hope Lung Foundation - Treatment and Management of Lung Cancer Video
http://www.youandlungcancer.com/en-lc/view/m401-a05-treatment-and-management-of-non-small-cell-lung-cancer-nsclc-animation

American Cancer Society
https://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/immunotherapy.html

Journal article referenced in this episode:
Hellmann, Matthew D. et al "Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLC." Clinical Cancer Research 26.12 (2020): 2849-2858. Web. 11 July. 2020.
https://clincancerres.aacrjournals.org/content/26/12/2849